- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/26 - Radicals substituted by halogen atoms or nitro radicals
Patent holdings for IPC class C07D 213/26
Total number of patents in this class: 218
10-year publication summary
|
20
|
17
|
12
|
14
|
8
|
12
|
15
|
9
|
9
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Dow AgroSciences LLC | 1179 |
8 |
| Novartis AG | 10175 |
6 |
| Mycovia Pharmaceuticals, Inc. | 40 |
6 |
| Merck Sharp & Dohme LLC | 3738 |
6 |
| UDC Ireland Limited | 505 |
5 |
| Agc, Inc. | 5590 |
5 |
| Sumitomo Chemical Company, Limited | 8969 |
4 |
| The Regents of the University of Michigan | 5023 |
4 |
| Essilor International (compagnie Generale D'optique) | 2995 |
4 |
| Nankai University | 263 |
4 |
| Rigel Pharmaceuticals, Inc. | 520 |
4 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3014 |
4 |
| Corteva Agriscience LLC | 2646 |
4 |
| Bristol-myers Squibb Company | 4764 |
3 |
| Samsung Display Co., Ltd. | 38914 |
3 |
| Daikin Industries, Ltd. | 10513 |
3 |
| FMC Corporation | 813 |
3 |
| Osaka University | 3261 |
3 |
| The United States of America, as represented by the Secretary, Department of Health & Human Services | 220 |
3 |
| Universal Display Corporation | 2098 |
3 |
| Other owners | 133 |